
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $62M | -- | -- | -- | -- |
08/14/2025 | Q2 | $59.4M | -- | -- | -- | -- |
05/15/2025 | Q1 | $39M | $40.2M | -$0.21 | -- | -- |
12/31/2024 | Q4 | $53M | $58.6M | -$0.10 | -- | -- |
11/14/2024 | Q3 | $65.6M | $60.1M | -$0.31 | -- | -- |
08/14/2024 | Q2 | $57.3M | $46.8M | -$0.57 | -- | -- |
05/15/2024 | Q1 | $44M | $45.1M | -$0.59 | -- | -- |
12/31/2023 | Q4 | $51.9M | $45.3M | -$0.56 | -- | -- |
11/15/2023 | Q3 | $66.8M | $66.6M | -$0.20 | -- | -- |
08/14/2023 | Q2 | $68.5M | $65.1M | -$0.12 | -- | -- |
05/15/2023 | Q1 | -- | $45.8M | -$0.50 | -- | -- |
12/31/2022 | Q4 | -- | $47.2M | -$0.60 | -- | -- |
11/09/2022 | Q3 | -- | $51.2M | -$0.23 | -- | -- |
08/09/2022 | Q2 | -- | $64.5M | -$0.11 | -- | -- |
05/10/2022 | Q1 | -- | $40.2M | -$0.70 | -- | -- |
03/16/2022 | Q4 | -- | $49.9M | $0.01 | -- | -- |
11/09/2021 | Q3 | -- | $31.8M | -$0.46 | -- | -- |
08/09/2021 | Q2 | -- | $36M | $1.01 | -- | -- |
05/17/2021 | Q1 | -- | $21.3M | $0.86 | -- | -- |
12/31/2020 | Q4 | -- | $15M | -$0.80 | -- | -- |
11/09/2020 | Q3 | -- | $10.2M | -$0.88 | -- | -- |
08/10/2020 | Q2 | -- | $3.4M | -$1.04 | -- | -- |
06/25/2020 | Q1 | -- | $49.2M | -$0.27 | -- | -- |
03/16/2020 | Q4 | -- | $68.9M | -$1.25 | -- | -- |
11/13/2019 | Q3 | -- | $70.4M | $0.04 | -- | -- |
08/09/2019 | Q2 | -- | $76M | $0.10 | -- | -- |
05/13/2019 | Q1 | -- | $61.5M | -$0.09 | -- | -- |
03/18/2019 | Q4 | -- | $74.5M | $0.21 | -- | -- |
11/06/2018 | Q3 | -- | $74.3M | $0.06 | -- | -- |
08/09/2018 | Q2 | -- | $84.3M | $0.22 | -- | -- |
05/11/2018 | Q1 | -- | $75.9M | $0.13 | -- | -- |
03/16/2018 | Q4 | -- | $71.5M | $0.32 | -- | -- |
11/06/2017 | Q3 | -- | $66.1M | $0.07 | -- | -- |
08/08/2017 | Q2 | -- | $72.4M | $0.81 | -- | -- |
05/09/2017 | Q1 | -- | $69.5M | $0.13 | -- | -- |
03/13/2017 | Q4 | -- | $67.8M | $0.01 | -- | -- |
11/10/2016 | Q3 | -- | $71.3M | $0.16 | -- | -- |
08/10/2016 | Q2 | -- | $66.9M | $0.13 | -- | -- |
05/02/2016 | Q1 | -- | $64.8M | $0.09 | -- | -- |
03/31/2016 | Q4 | -- | $66.7M | $0.14 | -- | -- |
11/06/2015 | Q3 | -- | $57.8M | $0.02 | -- | -- |
Reading International reported $40.2M worth of top line sales in its most recent quarter.
Reading International announced earnings per share of -$0.21 which represents a miss of analyst forecast a -- per share.
Reading International reported $1.6M that represents $0.07 per share over the last quarter.
Reading International's earnings are forecast to grow from -$1.58 per share to -- per share next year representing an increase of --.
Reading International's next earnings date is August 14, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.